Caricamento...
Chimeric Antigen Receptor (CAR)-Engineered Lymphocytes for Cancer Therapy
INTRODUCTION: Chimeric antigen receptors (CARs) usually combine the antigen binding site of a monoclonal antibody with the signal activating machinery of a T cell, freeing antigen recognition from major histocompatibility complex restriction and thus breaking one of the barriers to more widespread a...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107373/ https://ncbi.nlm.nih.gov/pubmed/21463133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2011.573476 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|